Honoree Selection Criteria

Call for Nominations for 2015 Awards of Excellence Honorees in Basic Science, Clinical Development, Medicine, Advocacy and Philanthropy. Please nominate candidates by filling out this form (Click here for form) and returning it Hope Funds for Cancer Research by mail (174 Bellevue Avenue, Suite 311, Newport, RI 02840) or scan and send by email to programs@hope-funds.org

The Hope Funds for Cancer Research works to identify the very best awardees for its annual Awards. Honorees should be at the top of their fields and have strong appeal to those interested in supporting the Hope Funds for Cancer Research.

Potential awardees are suggested by Trustees and Advisors of the Hope Funds for Cancer Research to the Programs Committee by a formal nomination process.

All candidates are evaluated on their service in the field of cancer research and treatment, significant contributions in advancing cancer care, integrity and character, and how they are regarded by their peers. In addition, candidates in individual categories should have the following qualities:

  • In basic science, the candidate should be a true luminary in the field of cancer research, having advanced the knowledge of cancer biology.
  • In developmental science, the candidate should have developed a means of prevention, a treatment or a diagnostic that has meaningfully and significantly improved patient outcomes as measured by increased life-expectancy and/or improved quality of life.
  • In medicine, the candidate should have developed a procedure or made a discovery in the field of oncology that has meaningfully and significantly improved patient outcomes as measured by increased life-expectancy and/or improved quality of life.
  • In advocacy, the candidate may be an organization, or preferably an individual, who has served the needs of cancer patients and their families, by providing care and compassion and by bringing attention to the disease.
  • In philanthropy, the candidate may be an organization, or preferably an individual, who has made exceptional contributions that have furthered cancer research, treatment and support of patients and their families.
  • Honorees shall be selected without regard or prejudice as to race, color, religion, sex, age, creed or national origin.